Optometrists in Hartsdale, NY Accepting Medicare

6 Optometrists found. Showing 1 - 6

Sterling Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 421 N Central Ave, Hartsdale, NY 10530 Phone: 914-400-4434

Central Eyes Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 161 S Central Ave, Hartsdale, NY 10530 Phone: 914-948-1700    Fax: 914-948-7078

Dr. Arlene Ziedenweber-schwartz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 221 E Hartsdale Ave, Hartsdale, NY 10530 Phone: 914-725-1600    Fax: 914-713-7216

Hartsdale Family Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 221 E Hartsdale Ave, Ste B Fl 2, Hartsdale, NY 10530 Phone: 917-725-1600    Fax: 508-484-2008

Metro Optics Hartsdale Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 161 South Central Park Av, Hartsdale, NY 10530 Phone: 914-948-1700    Fax: 914-948-7078

Jeffrey Cooper O.d., P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 161 South Central Park Avenue, Hartsdale, NY 10530 Phone: 914-948-1700

News Archive

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ: APCVZ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market penicillin G potassium for Injection, USP, in two dosage strengths. Penicillin G is therapeutically equivalent to the reference drug PfizerPen™ G, which is marketed by the innovator Pfizer, Inc.

Better transitions of care can decrease likelihood of hospital readmissions

Hospital discharge after serious conditions are rife with potential for complication and confusion. Patients are often loaded with details that can be difficult to understand and process when dealing with the weight of surviving a heart attack.

Study highlights the psychological and social concerns of musculoskeletal trauma patients

Musculoskeletal injuries comprise a large percentage of hospital admissions for adults and often lead to chronic pain and long-term disability.

BU researcher gets prestigious fellowship to launch new project for people with dementia

A Bournemouth University researcher has been awarded a prestigious fellowship to launch a health and wellbeing project for people with dementia.

Read more Medical News

› Verified 3 days ago